SEC Form D · Amendment · filed December 10, 2013
Aprecia Pharmaceuticals Co
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
David Furniss · CINCINNATI, OHExecRobert Williford · CINCINNATI, OHExecPhilip Cater · George Town, Grand Cayman, Cayman IslandsDirectorLawrence Glassmann · Cincinnati, OHDirectorDonald Wetherhold · LOVELAND, OHExecMichael Rohlfs · WEST CHESTER, OHExecE T. Arington · Mason, OHDirectorArthur R. Rule, Iv · Toronto, Ontario, CanadaDirectorMichael Lipomi · Dallas, TXDirectorShawn Leimbrock · Santa Barbara, CAExecMarti Ogram · Santa Barbara, CAExecMichael Franco · Santa Barbara, CAExecMatthew Ehrlichman · Seattle, WAExecE T. Arington · Mason, OHDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗